[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356712-105":59,"doc-detail-356712-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","targeting-prmts-creates-vulnerability-of-dna-double-stand-break-repair-pathways-and-potentiates-chemotherapy-efficacy-in-tnbc","Targeting PRMTs Creates Vulnerability of DNA Double-Stand Break Repair Pathways, and Potentiates Chemotherapy Efficacy in TNBC","","Patients with triple-negative breast cancer (TNBC) are treated with chemotherapies that induce DNA damage, yet about 30% develop resistance due to enhanced DNA repair capacity. PRMT1 and PRMT5, key protein arginine methyltransferases, regulate DNA repair signaling and help maintain DNA integrity. The study shows PRMT1/PRMT5 recruitment to DNA double-strand breaks after doxorubicin or carboplatin and preferential involvement in homologous recombination. PRMT inhibition combined with these drugs increases DNA breaks, reduces TNBC proliferation and clonogenicity in vitro, and sensitizes patient-derived TNBC models to carboplatin, supporting clinical evaluation of PRMT inhibitors as combinatorial agents.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeting-prmts-creates-vulnerability-of-dna-double-stand-break-repair-pathways-and-potentiates-chemotherapy-efficacy-in-tnbc/356712/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeting-prmts-creates-vulnerability-of-dna-double-stand-break-repair-pathways-and-potentiates-chemotherapy-efficacy-in-tnbc/356712.png","ImageObject",300,407,{"name":92,"@type":93},"Fahsai","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in triple-negative breast cancer treatment?","Question",{"text":112,"@type":113},"It addresses chemotherapy resistance in TNBC, which is linked to increased DNA repair mechanisms that allow cancer cells to escape DNA-damaging therapies.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which enzymes are central to the proposed strategy?",{"text":117,"@type":113},"The study focuses on PRMT1 and PRMT5, the two main protein arginine methyltransferases involved in DNA repair signaling.",{"name":119,"@type":110,"acceptedAnswer":120},"How do PRMT inhibitors affect chemotherapy response?",{"text":121,"@type":113},"Combining PRMT inhibitors with doxorubicin or carboplatin increases DNA double-strand breaks, impairs TNBC cell proliferation and clonogenicity in vitro, and sensitizes patient-derived models to carboplatin.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356712,1790811228,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549768702563,"https://ap-avatar.wpscdn.com/avatar/8000c4aa63b76e948b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786536092046926083","Cancer Science  \nORIGINAL ARTICLE  OPEN ACCESS   \nCarcinogenesis  \nTargeting PRMTs Creates Vulnerability of DNA Double-Stand Break Repair Pathways, and Potentiates Chemotherapy Efficacy in TNBC  \nCharlène Thiebaut1,2,3 | Sébastien Martinez1,2,3 | Ludivine Pruvost1,2,3 | Louisane Eve1,2,3 | Rania El-Botty4 | Laura Sourd4 | Elodie Montaudon4 | Ahmed Dahmani4 | Heloise Derrien4 | Stéphanie Sentis1,2,3 | Coralie Poulard1,2,3 |  \nElisabetta Marangoni4 | Olivier Trédan1,2,3,5 | Muriel Le Romancer1,2,3   \n1Université Claude Bernard Lyon 1, Lyon, France | 2Inserm U1052, Centre de Recherche en Cancérologie de Lyon, Lyon, France | 3CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, Lyon, France | 4Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, Paris, France | 5Oncology Department, Centre Leon Bérard, Lyon, France  \nCorrespondence: Muriel Le Romancer ([muriel.leromancer@lyon.unicancer.fr](muriel.leromancer@lyon.unicancer.fr))  \nReceived: 25 September 2025 | Revised: 19 January 2026 | Accepted: 21 January 2026  \nKeywords: arginine methylation | DNA-damage repair | PRMT1 | PRMT5 | triple-negative breast cancer  \nABSTRACT  \nPatients with triple-negative breast cancer (ER − , PR − , and HER2−) are routinely treated with chemotherapies that induce DNA damage. However, around 30% of patients display resistance, owing largely to increased DNA repair mechanisms, upregulated to allow cancer cells to escape such therapies. PRMT1 and PRMT5, the two main protein arginine methyltransferases, are involved in several biological pathways, including DNA repair signaling, where they contribute to ensuring DNA integrity. We then speculated that targeting their enzymatic activity may sensitize TNBC cells to chemotherapeutic agents inducing DNA double-strand breaks. Here, we showed that PRMT1 and PRMT5 are recruited to DNA double-strand breaks upon doxorubicin or carboplatin treatment, two chemotherapies currently used to treat TNBC patients, and are preferentially involved in the homologous recombination pathway. By combining PRMT inhibitors with doxorubicin or carboplatin, we increased DNA double-strand breaks and impaired TNBC cell proliferation and clonogenicity in vitro and sensitized patient-derived models of TNBC to carboplatin treatment. These preclinical data provide a rationale for the clinical evaluation of PRMT inhibitors as combinatorial agents to improve chemotherapy efficacy for TNBC patients.  \n1 | Introduction  \nTriple-negative breast cancers (TNBC) are defined by the absence of estrogen and progesterone receptor expression and HER2  \namplification. This highly aggressive breast cancer subtype accounts for approximately 15% of breast cancers, and patients are more prone to recurrence and metastasis [1] . Routine chemotherapeutic options for these patients include anthracyclines,  \n\n| Abbreviations: 53BP1, p53-binding protein 1; aDMA, asymmetric dimethyl arginine; ATCC, American Type Culture Collection; BRCA1, breast cancer gene 1; BRCA2, breast cancer gene 2; BSA, bovine serum albumin; Carbo, carboplatin; CRISPR, clustered regularly interspaced short palindromic repeats; DAPI, 4′,6-diamidino-2-phénylindole; DMSO, dimethyl sulfoxide; DNA, deoxyribonucleic acid; DNA-PK, DNA-dependent protein kinase catalytic subunit; Doxo, doxorubicin; DSB, double-strand breaks; EDTA, ethylenediaminetetraacetic acid; G595, GSK3326595; G715, GSK3368715; H2AX, H2A histone family member X; HER2, human epidermal growth factor receptor-2; HR, homologous recombination; MMA, monomethyl arginine; NHEJ, non-homologous end joining; PBS, phosphate buffered saline; PCR, polymerase chain reaction; PDO, patient derived organoids; PDX, patient derived xenograft; PLA, proximity ligation assay; PRMT, protein arginine methyltransferases; PRMT1, protein arginine methyltransferase 1; PRMT5, protein arginine methyltransferase 5; PRMT6, protein arginine\u003Cbr>methyltransferase 6; PRMT8, protein arginine methyltransfe","cbCaiqshhFEYr0Wf","https://ap.wps.com/l/cbCaiqshhFEYr0Wf","pdf",1922206,13,"English","# Introduction\n## Targeting PRMTs and DNA repair pathways in TNBC","[{\"question\":\"What problem does the study address in triple-negative breast cancer treatment?\",\"answer\":\"It addresses chemotherapy resistance in TNBC, which is linked to increased DNA repair mechanisms that allow cancer cells to escape DNA-damaging therapies.\"},{\"question\":\"Which enzymes are central to the proposed strategy?\",\"answer\":\"The study focuses on PRMT1 and PRMT5, the two main protein arginine methyltransferases involved in DNA repair signaling.\"},{\"question\":\"How do PRMT inhibitors affect chemotherapy response?\",\"answer\":\"Combining PRMT inhibitors with doxorubicin or carboplatin increases DNA double-strand breaks, impairs TNBC cell proliferation and clonogenicity in vitro, and sensitizes patient-derived models to carboplatin.\"}]","Targeting PRMTs Creates Vulnerability of DNA Double-Stand Break Repair Pathways, and Potentiates Chemotherapy Efficacy in TNBC | PDF",1790126908,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b49c6dcb3a5c945adbd13edfa34997e2.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/49e2bd1d7e8842acb5a1778d6e0b249d.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8ee2f0d6eea41d17b1db2997eed11ae6.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/002ae60cfe097539b4c60c6a17bfcd0b.webp",980,1287]